Future Proof Process Design Through Risk-Focused Decisions, Automation Readiness, And Regulatory Pragmatism

In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene share that future proofing begins with deep process understanding. They state that developers must identify the biggest pain points, map a prioritized roadmap, and invest where they’ll get the most value for compliance, scaling, or phenotype control.